Skip to main content
Clinical Trials/CTRI/2022/11/046964
CTRI/2022/11/046964
Not yet recruiting
未知

Exploring the utility of artificial intelligence augmented functional connectomics approach in brain tumors: a prospective cohort study

BrainSight Technology Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
BrainSight Technology Pvt. Ltd.
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
BrainSight Technology Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • Glioma diagnosis
  • Eligible for surgical resection

Exclusion Criteria

  • Anyone \<18 and \>60 years of age
  • History of primary neurological disorders including seizure disorders/pre\-existing disorders of development and degenerative disorders involving structural changes
  • Primary/pre\-existing development and degenerative disorder involving structural changes
  • Primary/pre\-existing Movement, Vision and speech disorders
  • Surgery in adjunct with cranial radiotherapy
  • Follow\-up cases
  • Patients with contraindications to magnetic resonance imaging scanning
  • Pregnant women
  • Cases of meningioma

Outcomes

Primary Outcomes

Not specified

Similar Trials